adult acute promyelocytic leukemia (M3)
Information
- Disease name
- adult acute promyelocytic leukemia (M3)
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01869803 | Approved for marketing | Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia | |||
| NCT00005064 | Completed | Phase 1 | PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome | February 2000 | |
| NCT00006213 | Completed | Phase 1 | BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia | April 2000 | |
| NCT00062075 | Completed | Phase 2 | Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | May 2003 | |
| NCT00098826 | Completed | Phase 1 | SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes | December 2004 | |
| NCT00301938 | Completed | Phase 1 | 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes | December 2005 | |
| NCT00305773 | Completed | Phase 2 | Vorinostat in Treating Patients With Acute Myeloid Leukemia | January 2006 | January 2010 |
| NCT00331513 | Completed | Phase 1 | Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes | March 2006 | |
| NCT00357305 | Completed | Phase 1 | Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders | May 2006 | |
| NCT00003934 | Completed | Phase 3 | Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia | June 1999 | |
| NCT00602225 | Completed | Phase 1/Phase 2 | Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | December 2007 | April 2015 |
| NCT01031368 | Completed | Phase 1 | Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia | December 2009 | October 24, 2012 |
| NCT01146223 | Completed | Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia | September 2009 | June 2011 | |
| NCT01177371 | Completed | Phase 2 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | March 1988 | February 2010 |
| NCT00588809 | Completed | Phase 2 | Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia | December 2007 | December 2012 |
| NCT01588015 | Completed | Phase 1 | Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant | October 29, 2012 | February 2, 2024 |
| NCT01465386 | Terminated | Phase 2 | Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission | November 2011 | March 2, 2015 |
| NCT01548911 | Withdrawn | Phase 2 | Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia | May 2012 | September 2013 |